Cathy Klema is Director at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI). They have made 5 open-market trades across 3 companies since 2006, most recently 2026-06-09.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACT | SELL | 2013-08-12 | 2013-08-14 | $133.03 | $222K | +0.0% | +0.0% | +0.0% |
| WPI | SELL | 2012-07-31 | 2012-08-01 | $78.38 | $1.3M | N/A | N/A | N/A |
| PPDI | SELL | 2008-05-28 | 2008-05-29 | $43.59 | $349K | N/A | N/A | N/A |
| PPDI | SELL | 2007-05-23 | 2007-05-23 | $35.47 | $426K | N/A | N/A | N/A |
| PPDI | SELL | 2006-02-27 | 2006-02-28 | $70.09 | $280K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.